Europe

FDA Grants Inhaled Use IND for RLF-100 (Aviptadil) to Treat Patients With Moderate and Severe COVID-19 Aiming to Prevent Progression to Respiratory Failure

Thursday, August 6, 2020 - 6:30am

The first phase will commence with patients hospitalized for severe COVID-19 who do not yet have respiratory failure.

Key Points: 
  • The first phase will commence with patients hospitalized for severe COVID-19 who do not yet have respiratory failure.
  • The clinical trial of the inhaled formulation of RLF-100 is expected to begin on or before September 1, 2020.
  • Vasoactive Intestinal Polypeptide (VIP) was first discovered by the late Dr. Sami Said in 1970.
  • Before this acute phase, however, there is evidence of early viral infection of the alveolar type 2 cells.

Vifor Pharma Group Reports Continued Growth in H1 2020

Thursday, August 6, 2020 - 6:00am

Vifor Pharma Group reported growth in H1 2020, despite challenges to patient access conditions caused by the COVID-19 pandemic.

Key Points: 
  • Vifor Pharma Group reported growth in H1 2020, despite challenges to patient access conditions caused by the COVID-19 pandemic.
  • However, growth was sustained in the nephrology area, mostly driven by the dialysis business.
  • Commenting on the first half results, Stefan Schulze, CEO of Vifor Pharma Group, said:
    Despite unprecedented challenges due to COVID-19, we are pleased to report overall sustained revenue growth and a strong EBITDA growth in H1 2020.
  • We maintained growth in the nephrology area, driven by the dialysis business, further underlining the success of our therapeutic diversification in recent years.

Fish and Seafood Market in Romania 2020-2024 | Expansion of Retail Landscape to Boost Growth | Technavio

Thursday, August 6, 2020 - 1:15am

Our fish and seafood market in Romania report covers the following areas:

Key Points: 
  • Our fish and seafood market in Romania report covers the following areas:
    This study identifies rising awareness about the benefits of seafood consumption as one of the prime reasons driving the fish and seafood market growth in Romania during the next few years.
  • Fish and Seafood Market in Romania 2020-2024: Vendor Analysis
    We provide a detailed analysis of vendors operating in the fish and seafood market in Romania, including some of the vendors such as Dayseaday Fresh B.V., Negro 2000 SRL, NORDIC IMPORT EXPORT CO SRL, SC Macromex SRL, SC MEDASIMPEX SRL, SC Miadmar HDP SRL, SC Ocean Fish SRL, SC RADAN IMPEX SA, Serpico Trading SRL, and STORE FISH & SEAFOOD SRL.
  • Backed with competitive intelligence and benchmarking, our research reports on the fish and seafood market in Romania are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Fish and Seafood Market in Romania 2020-2024: Key Highlights

MSCI August Quarterly Index Review Announcement Scheduled for August 12, 2020

Wednesday, August 5, 2020 - 11:14pm

MSCI Inc. (NYSE:MSCI), a leading provider of research-based indexes and analytics, will announce the results of the August 2020 Quarterly Index Review for the MSCI Equity Indexes - including the MSCI Global Standard, MSCI Global Small Cap and MSCI Micro Cap Indexes, the MSCI Global Value and Growth Indexes, the MSCI Frontier Markets, and MSCI Frontier Markets Small Cap Indexes, the MSCI Frontier Emerging Markets Index, the MSCI Global Islamic and MSCI Global Islamic Small Cap Indexes, the MSCI Pan-Euro and MSCI Euro Indexes, the MSCI US Equity Indexes, the MSCI US REIT Index, the MSCI China A Onshore Indexes and the MSCI China All Shares Indexes.

Key Points: 
  • MSCI Inc. (NYSE:MSCI), a leading provider of research-based indexes and analytics, will announce the results of the August 2020 Quarterly Index Review for the MSCI Equity Indexes - including the MSCI Global Standard, MSCI Global Small Cap and MSCI Micro Cap Indexes, the MSCI Global Value and Growth Indexes, the MSCI Frontier Markets, and MSCI Frontier Markets Small Cap Indexes, the MSCI Frontier Emerging Markets Index, the MSCI Global Islamic and MSCI Global Islamic Small Cap Indexes, the MSCI Pan-Euro and MSCI Euro Indexes, the MSCI US Equity Indexes, the MSCI US REIT Index, the MSCI China A Onshore Indexes and the MSCI China All Shares Indexes.
  • MSCI will post the list of additions to and deletions from the indexes for the August 2020 Quarterly Index Review on its web site, www.msci.com , shortly after 11:00 p.m. Central European Summer Time (CEST) on August 12, 2020.
  • Clients can access the subscriber section of each index at: www.msci.com/index-review-subscribers
    For the MSCI US Equity Indexes and the MSCI US REIT Index, a summary of the announcement will be made available at www.msci.com .
  • Accordingly, constituents in MSCI equity indexes may include MSCI Inc., clients of MSCI or suppliers to MSCI.

AM Best Affirms Credit Ratings of Members of AmFirst Holdings, Inc. and AmFirst Specialty Insurance Company

Wednesday, August 5, 2020 - 10:14pm

AM Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of a- of AmFirst Insurance Company (AmFirst) (Oklahoma City, OK) and its wholly owned subsidiaries, Monitor Life Insurance Company of New York (Monitor Life) (Utica, NY), AmFirst Life Insurance Company, I.I.

Key Points: 
  • AM Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of a- of AmFirst Insurance Company (AmFirst) (Oklahoma City, OK) and its wholly owned subsidiaries, Monitor Life Insurance Company of New York (Monitor Life) (Utica, NY), AmFirst Life Insurance Company, I.I.
  • Concurrently, AM Best has affirmed the FSR of B++ (Good) and the Long-Term ICR of bbb+ of AmFirsts subsidiary, AmFirst Specialty Insurance Company (AmFirst Specialty) (Ridgeland, MS).
  • The ratings also benefit from the implicit and explicit support of its immediate parent, AmFirst Insurance Company, and its ultimate parent, AmFirst Holdings, Inc. (AHI).
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .

Horizon Therapeutics plc Announces Proposed Public Offering of Ordinary Shares

Wednesday, August 5, 2020 - 9:01pm

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it is offering to sell $700,000,000 of its ordinary shares in an underwritten public offering.

Key Points: 
  • Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it is offering to sell $700,000,000 of its ordinary shares in an underwritten public offering.
  • The Company also expects to grant the underwriters a 30-day option to purchase up to an additional $105,000,000 of ordinary shares in the public offering.
  • Citigroup, Morgan Stanley, J.P. Morgan, Piper Sandler and Stifel are acting as joint book-running managers for the offering.
  • This press release contains forward-looking statements, including, but not limited to, statements related to the completion, timing and size of the proposed public offering of ordinary shares by Horizon Therapeutics and the expected use of proceeds from the proposed public offering.

Bicycle Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conference

Wednesday, August 5, 2020 - 9:05pm

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced that management will participate in a fireside chat at the Canaccord Genuity 40th Annual Growth Conference on Wednesday, August 12, 2020 at 8:00 a.m.

Key Points: 
  • Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced that management will participate in a fireside chat at the Canaccord Genuity 40th Annual Growth Conference on Wednesday, August 12, 2020 at 8:00 a.m.
  • A live webcast of the fireside chat will be accessible in the Investors & Media section of Bicycles website at www.bicycletherapeutics.com .
  • Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics.
  • Bicycle is headquartered in Cambridge, UK with many key functions and members of its leadership team located in Lexington, MA.

Zynga Enters Into Agreement to Acquire Istanbul-based Rollic, One of the Fastest Growing Hyper-Casual Mobile Game Companies

Wednesday, August 5, 2020 - 9:06pm

With this acquisition, Zynga enters the hyper-casual market one of the largest and fastest growing gaming categories on mobile and adds a highly talented team and an extensive network of external developers.

Key Points: 
  • With this acquisition, Zynga enters the hyper-casual market one of the largest and fastest growing gaming categories on mobile and adds a highly talented team and an extensive network of external developers.
  • Rollics titles currently have more than 5 million mobile daily active users (DAUs) and 65 million mobile monthly active users (MAUs).
  • With Rollic, we are meaningfully growing our audience, expanding and diversifying our global advertising business, and adding to our game pipeline and developer network.
  • Average Mobile MAUs for a particular period is the average of the Mobile MAUs at each month-end during that period.

AM Best Affirms Credit Ratings of Jupiter Insurance Limited

Wednesday, August 5, 2020 - 6:46pm

AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of a of Jupiter Insurance Limited (Jupiter) (Guernsey), a captive of BP p.l.c.

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of a of Jupiter Insurance Limited (Jupiter) (Guernsey), a captive of BP p.l.c.
  • For current Bests Credit Ratings and independent data on the captive and alternative risk transfer insurance market, please visit www.ambest.com/captive .
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper media use of Bests Credit Ratings and AM Best press releases, please view Guide for Media - Proper Use of Bests Credit Ratings and AM Best Rating Action Press Releases .